Peptide Inhibitor of Complement C1, a Novel Suppressor of Classical Pathway Activation: Mechanistic Studies and Clinical Potential
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Peptide Inhibitor of Complement C1, a Novel Suppressor of Classical Pathway Activation: Mechanistic Studies and Clinical Potential
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 5, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2014-08-22
DOI
10.3389/fimmu.2014.00406
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Peptide inhibitors of C3 activation as a novel strategy of complement inhibition for the treatment of paroxysmal nocturnal hemoglobinuria
- (2014) Antonio M. Risitano et al. BLOOD
- TNT003, an inhibitor of the serine protease C1s, prevents complement activation induced by cold agglutinins
- (2014) J. Shi et al. BLOOD
- Complement inhibition significantly decreases red blood cell lysis in a rat model of acute intravascular hemolysis
- (2014) Tushar A. Shah et al. TRANSFUSION
- C1-esterase inhibitor concentrate rescues erythrocytes from complement-mediated destruction in autoimmune hemolytic anemia
- (2013) D. Wouters et al. BLOOD
- Eculizumab: A Review of Its Use in Atypical Haemolytic Uraemic Syndrome
- (2013) Gillian M. Keating DRUGS
- Complement in Immune and Inflammatory Disorders: Therapeutic Interventions
- (2013) D. Ricklin et al. JOURNAL OF IMMUNOLOGY
- Expression of recombinant human complement C1q allows identification of the C1r/C1s-binding sites
- (2013) I. Bally et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Initiation and Regulation of Complement during Hemolytic Transfusion Reactions
- (2012) Sean R. Stowell et al. Clinical & Developmental Immunology
- A novel peptide inhibitor of classical and lectin complement activation including ABO incompatibility
- (2012) Clifford T. Mauriello et al. MOLECULAR IMMUNOLOGY
- Case Report: Eculizumab Rescue of Severe Accelerated Antibody-Mediated Rejection After ABO-Incompatible Kidney Transplant
- (2012) Z.A. Stewart et al. TRANSPLANTATION PROCEEDINGS
- Nafamostat Mesilate as an Anticoagulant during Continuous Veno-Venous Hemodialysis: A Three-Year Retrospective Cohort Study
- (2011) Yukio Maruyama et al. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
- C1-Inhibitor: More Than a Serine Protease Inhibitor
- (2011) Sacha Zeerleder SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Potent inhibition of the classical pathway of complement by a novel C1q-binding peptide derived from the human astrovirus coat protein
- (2010) Jenny Q. Gronemus et al. MOLECULAR IMMUNOLOGY
- Use of mouse models to study the mechanisms and consequences of RBC clearance
- (2010) E. A. Hod et al. VOX SANGUINIS
- Analogous Interactions in Initiating Complexes of the Classical and Lectin Pathways of Complement
- (2009) A. E. Phillips et al. JOURNAL OF IMMUNOLOGY
- Human astrovirus coat protein binds C1q and MBL and inhibits the classical and lectin pathways of complement activation
- (2009) Pamela S. Hair et al. MOLECULAR IMMUNOLOGY
- Treatment With Intravenous Immunoglobulin and Steroids May Correct Severe Anemia in Hyperhemolytic Transfusion Reactions: Case Report and Literature Review
- (2009) Nay Win et al. TRANSFUSION MEDICINE REVIEWS
- Biphenylsulfonyl-thiophene-carboxamidine inhibitors of the complement component C1s
- (2008) Jeremy M. Travins et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Hemolytic Transfusion Reactions
- (2008) Erwin Strobel TRANSFUSION MEDICINE AND HEMOTHERAPY
- Autoimmune hemolytic anemia: classification and therapeutic approaches
- (2008) Pascal Sève et al. Expert Review of Hematology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More